Whitehawk Therapeutics Inc (WHWK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,824 | -14,176 | -8,493 | -10,397 | -1,878 |
| Depreciation Amortization | 54 | 34 | 13 | 47 | 35 |
| Accounts payable and accrued liabilities | N/A | -2,046 | -1,714 | 1,865 | 53 |
| Other Working Capital | -2,089 | -1,308 | -1,220 | 1,110 | -544 |
| Other Operating Activity | 1,872 | 3,272 | 2,335 | 1,567 | 2,711 |
| Operating Cash Flow | $-18,988 | $-14,224 | $-9,078 | $-5,808 | $377 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -237 | -233 | -113 | -38 | -29 |
| Investing Cash Flow | $-237 | $-233 | $-113 | $-38 | $-29 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 51,698 | 51,698 |
| Other Financing Activity | 0 | 0 | 0 | -3,503 | -3,503 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $48,196 | $48,196 |
| Beginning Cash Position | 62,614 | 62,614 | 62,614 | 20,264 | 20,264 |
| End Cash Position | 43,390 | 48,157 | 53,423 | 62,614 | 68,807 |
| Net Cash Flow | $-19,224 | $-14,457 | $-9,192 | $42,350 | $48,543 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,988 | -14,224 | -9,078 | -5,808 | 377 |
| Capital Expenditure | -237 | -233 | -113 | -38 | -29 |
| Free Cash Flow | -19,225 | -14,457 | -9,192 | -5,846 | 347 |